Table 1.
Median (range) | |
---|---|
Age (years) | 68 (19–101) |
Weight (kg) | 70 (32–110) |
Ciprofloxacin i.v. (days) | 8 (2–45) |
Admission (days) | 20 (5–122) |
CRP before therapy (mg l−1) | 203 (1–469) |
CRP after therapy (mg l−1) | 67 (3–405) |
Gender | Frequency (percentage) |
Male | 48 (60%) |
Female | 32 (40%) |
Infection | Frequency (percentage) |
Pneumonia | 26 (33%) |
Wound infection | 18 (23%) |
UTI | 18 (23%) |
Sepsis | 8 (10%) |
Abdominal infection | 6 (6%) |
Other | 4 (5%) |
Ciprofloxacin combination with | Frequency (percentage) |
Monotherapy | 18 (23%) |
ß-lactam antibiotics | 45 (56%) |
Clindamycin | 9 (11%) |
Other | 8 (10%) |
Comedication | Frequency (percentage) |
None | 13 (16%) |
Cardiovascular | 35 (43%) |
Immunosupressive medication | 20 (25%) |
Diabetes mellitus | 10 (13%) |
Other | 15 (19%) |
UTI, urinary tract infection.